Phase 2 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 60 years of age
- People who have been diagnosed with major depressive disorder (a serious form of depression), whether it is their first episode or a recurring one
- People whose depression symptoms are at a moderate level or above, based on a standard rating scale called the MADRS (confirm with trial site)
- People who are currently looking to start treatment for their depression with antidepressant medication
- People who score above 24 on a standard memory and thinking test called the MoCA, meaning their general thinking abilities are largely intact
- People who are fluent in English or Spanish
Who may not be able to join:
- People who have another major psychiatric diagnosis, except for simple phobias or anxiety-related conditions (such as generalised anxiety or panic disorder) that only appeared during the current depressive episode
- People who have had a problem with alcohol or drug dependence or misuse in the past year
- People who have a history of a developmental disorder, or who have a history of an IQ below 70
- People who have had active thoughts of suicide in the past month, as assessed using a specific safety scale called the C-SSRS
- People who are in the very early stages of grief, within the past month
- People who currently have, or have previously had, psychosis (such as hallucinations or delusions)
- People who have a primary neurological condition, including dementia, stroke, brain tumours, epilepsy, or similar conditions
- People who have an unstable or serious physical health condition that needs urgent medical treatment
- People who have any reason they cannot safely have an MRI scan (confirm with trial site)
- People who have had electroconvulsive therapy (ECT), sometimes called shock therapy, within the past 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 312-413-4562
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency, Intensity and Burden of Side Effects Rating Scale; Montgomery-Asberg Rating Scale for Depression; Quantitative Anisotropy; Fractional Anisotropy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.